Abstract
Purpose: To report a case of probable Vogt-Koyanagi-Harada (VKH) leading to central serous chorioretinopathy (CSR) in the fellow eye following treatment with systemic steroids. Materials and methods: Patient presenting with unilateral probable VKH was treated with intravenous methylprednisolone and developed CSR in the fellow eye. This eye further went on to develop VKH eventually. Results: We describe an unusual case of probable VKH disease which developed CSR in the fellow eye following treatment and eventually developed characteristics of probable VKH in that eye too. Conclusion: CSR following systemic steroids is a well-known entity. In this case the patient developed CSR in the fellow eye of VKH and eventually developed characteristics of VKH. The clinical course along with the follow-up is discussed to manage this unique situation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
